Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
0
Business

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

April 27, 2026
Scroll

Posted 2 hours ago by

Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon Co., in what is likely to be one of the biggest India outbound deals in years.

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Bloomberg
Bloomberg

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America
Bias: lean left

People's Voices (0)

Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.
You might also like

Explore More